{"entity":{"id":"nct07075328","kind":"trial","name":"A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma","aka":[],"tldr":"A phase 1/2 trial of an investigational treatment in non-Hodgkin lymphoma, run by Otsuka Medical Devices Co., Ltd. Japan, now recruiting.","summary":"A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma is a phase 1/2 interventional study registered as NCT07075328 by Otsuka Medical Devices Co., Ltd. Japan, with 49 participants planned, started 2024-04-01 and due to reach its primary completion in 2028-02-28.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07075328","url":"https://clinicaltrials.gov/study/NCT07075328"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["non-hodgkin-lymphoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07075328","phase":"1/2","setting":"A Phase I/II Study of OJP-001 for Recurrent or Relapsed Adult T-cell Leukemia/Lymphoma Patients With Peripheral Blood Tumor.","sponsor":"Otsuka Medical Devices Co., Ltd. Japan","enrolled":49,"outcomes":[]},"route":"/trials/nct07075328/","neighbours":{"cancer":[{"id":"non-hodgkin-lymphoma","kind":"cancer","name":"Non-Hodgkin lymphoma (all types)","route":"/cancers/non-hodgkin-lymphoma/"}]}}